Aptiv PLCAPTVNYSE

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 70% recommend buying.

Consensus Rating

Buy

20 analysts·High coverage

70%

Rating Distribution

Strong Buy

00%

Buy

1470%

Hold

630%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 17% higher.

Bear Case

$84.00

+1%

Consensus

$97.30

+17%

Bull Case

$110.00

+33%

Price Range20 analysts

Low

Consensus

High

$84.00

$110.00

Current Target

Current Price

$82.93

Upside to Target

$14.37

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$8.47(12 analysts)

P/E63x

Current: 63.3x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.90%

EPS+10.95%

FY2028

Rev+6.65%

EPS+22.42%

FY2029

Rev+12.32%

EPS+7.87%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+10.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 14, 2026UBS

Aptiv price target raised to $99 from $94 at UBS

Target:$99.00

+12.2%from $88.25

Jan 13, 2026US Capital Advisors

Aptiv upgraded to Outperform from Equal-Weight at Fox Advisors

Target:$110.00

+26.7%from $86.83

Jan 8, 2026Piper Sandler

Aptiv upgraded to Overweight from Neutral at Piper Sandler

Target:$103.00

+25.4%from $82.15

Dec 8, 2025Morgan Stanley

Aptiv upgraded to Equal Weight from Underweight at Morgan Stanley

Target:$84.00

+10.0%from $76.37

Nov 24, 2025Evercore ISI

Aptiv price target raised to $100 from $95 at Evercore ISI

Target:$100.00

+33.8%from $74.72

Oct 31, 2025Oppenheimer

Aptiv price target raised to $94 from $92 at Oppenheimer

Target:$94.00

+14.5%from $82.12

Oct 31, 2025Wells Fargo

Aptiv price target lowered to $100 from $106 at Wells Fargo

Target:$100.00

+21.8%from $82.12

Oct 10, 2025RBC Capital

Aptiv price target raised to $101 from $92 at RBC Capital

Target:$101.00

+23.8%from $81.56

Oct 6, 2025UBS

Aptiv price target raised to $94 from $75 at UBS

Target:$94.00

+6.4%from $88.38

Sep 9, 2025Wells Fargo

Aptiv price target raised to $103 from $89 at Wells Fargo

Target:$103.00

+25.9%from $81.80

Sep 3, 2025Robert W. Baird

Aptiv price target raised to $97 from $84 at Baird

Target:$97.00

+21.8%from $79.63

Jul 16, 2025Barclays

Aptiv price target raised to $85 from $65 at Barclays

Target:$85.00

+21.2%from $70.13

Jul 11, 2025Robert W. Baird

Aptiv price target raised to $82 from $80 at Baird

Target:$82.00

+18.4%from $69.28

May 22, 2025Piper Sandler

Aptiv price target raised to $70 from $67 at Piper Sandler

Target:$70.00

+4.5%from $66.97

Dec 11, 2024Goldman Sachs

Aptiv price target lowered to $71 from $86 at Goldman Sachs

Target:$71.00

+21.5%from $58.42

Oct 1, 2024Industrial Alliance Securities

Aptiv price target lowered to $92 from $96 at Goldman Sachs

Target:$92.00

+27.8%from $72.01

Sep 20, 2024Wells Fargo

Wells Fargo Upgrades Aptive PLC. (APTV) to Overweight

Target:$87.00

+23.4%from $70.52

Sep 5, 2024RBC Capital

Aptive PLC. (APTV) PT Raised to $87 at RBC Capital

Target:$87.00

+24.2%from $70.05

Jul 16, 2024Barclays

Aptiv price target lowered to $105 from $110 at Barclays

Target:$105.00

+45.3%from $72.26

Jun 26, 2024Piper Sandler

Why This Aptiv Analyst Turns Bearish After The Deal Between Rivian, Volkswagen

Target:$63.00

-6.0%from $67.04

Feb 7, 2023Cowen & Co.

APTV Stock: $134 Price Target Received

Target:$134.00

+15.6%from $115.91

Feb 7, 2023Citigroup

Citigroup Maintains Buy on Aptiv, Raises Price Target to $138

Target:$138.00

+19.5%from $115.48

Feb 6, 2023Wells Fargo

Wells Fargo Maintains Equal-Weight on Aptiv, Raises Price Target to $115

Target:$115.00

-0.6%from $115.73

Feb 5, 2023Robert W. Baird

APTV Stock: $135 Price Target Received

Target:$135.00

+16.7%from $115.73

Feb 3, 2023Raymond James

Raymond James Maintains Outperform on Aptiv, Raises Price Target to $135

Target:$135.00

+13.8%from $118.68

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance